Research & Program Areas

Beating Cervical Cancer with a More Effective Vaccine

Every year more than 530,000 women are diagnosed with cervical cancer, and 88% of cervical cancer deaths occur in low- and middle-income countries. Cervical cancer is caused by the human papillomavirus (HPV) – a common virus transmitted through sexual contact. In this study, investigators from the US and Latin America are coming together to test the effectiveness of a new HPV vaccine, one that is both more effective at addressing HPV strains and more user friendly – requiring only two rather than three doses. The goal is to vaccinate 6000 girls age 10-14 from three countries with a high cervical cancer prevalence – Peru, Colombia, and Mexico – and follow them for up to 20 years.

Because CMCD has unique expertise in mobile health in Spanish-speaking countries, our researchers have been asked to develop a communication plan for using participants’ mobile phones to ensure follow-up assessments, gather information about sexual health, and provide information about how to avoid sexually-transmitted infections. The study is currently in the planning phase.

For more information, contact Nicolle Marinec at


Cancer, Children & Youth, Interactive Voice Response (IVR), International, Mobile Health, SMS & Text Messaging, Spanish-Speaking, Telephone

Return to Research and Program Areas